Christophe joined ArchiMed as Operating Partner in September 2019. Since mid-2018, Christophe has been Chairman of IAG Group, the imaging and AI business. Christophe has spent his 28-year career entirely within the CRO industry and enjoys a strong expertise and knowledge of the sector.
Prior to joining IAG Group, Christophe was CEO of UK based Synexus, a leading global SMO, between 2010 and 2017 and was then appointed as European CEO of Citoxlab (2018-2019).
In 2005, he moved to the US to lead the clinical division of CRL (Charles River Laboratories) and was promoted in 2007 to the position of Executive Corporate VP, Chief Commercial Officer for CRL Group. From 1990 to 2004, Christophe was with CRL Europe acting as Managing Director and Corporate VP of the Research Models Division.
Christophe Berthoux, is a doctor in veterinary medicine and holds an MBA from Purdue University, Indiana (US). Christophe is a British and French citizen. At ArchiMed, Christophe is particularly focused on the Biopharma Services sector.